Exelixis
EXEL
#1569
Rank
NZ$24.32 B
Marketcap
NZ$96.77
Share price
0.79%
Change (1 day)
30.19%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company